REGEN is not an approved drug, medicine, dietary supplement, or therapeutic agent
Dosing chart with 3mL water (3.33mg/mL) At this concentration, every unit equals approximately 0.033mg of semaglutide
Key target genes include those encoding components of the electron transport chain (ATP synthase subunits, cytochrome c), fatty acid oxidation enzymes (medium-chain acyl-CoA dehydrogenase, carnitine palmitoyltransferase 1), and transcription factors that amplify the metabolic signal (PGC-1 itself, NRF-1)
Common Side Effects: Injection site pain, headaches, dizziness, or mild diarrhea
There is no needle disposal concern
it does not guarantee that NAD+ therapy is appropriate for everyone